.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Covington
US Department of Justice
Mallinckrodt
Moodys
Colorcon
Healthtrust
Citi
McKinsey
Dow

Generated: June 27, 2017

DrugPatentWatch Database Preview

Calcium metrizoate; meglumine metrizoate; metrizoate magnesium; metrizoate sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for calcium metrizoate; meglumine metrizoate; metrizoate magnesium; metrizoate sodium and what is the scope of calcium metrizoate; meglumine metrizoate; metrizoate magnesium; metrizoate sodium freedom to operate?

Calcium metrizoate; meglumine metrizoate; metrizoate magnesium; metrizoate sodium
is the generic ingredient in one branded drug marketed by Ge Healthcare and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are two hundred and sixty-two drug master file entries for calcium metrizoate; meglumine metrizoate; metrizoate magnesium; metrizoate sodium.

Summary for Generic Name: calcium metrizoate; meglumine metrizoate; metrizoate magnesium; metrizoate sodium

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list262
Clinical Trials: see list4,213
Drug Prices:see low prices
DailyMed Link:calcium metrizoate; meglumine metrizoate; metrizoate magnesium; metrizoate sodium at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare
ISOPAQUE 440
calcium metrizoate; meglumine metrizoate; metrizoate magnesium; metrizoate sodium
INJECTABLE;INJECTION016847-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: calcium metrizoate; meglumine metrizoate; metrizoate magnesium; metrizoate sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge Healthcare
ISOPAQUE 440
calcium metrizoate; meglumine metrizoate; metrizoate magnesium; metrizoate sodium
INJECTABLE;INJECTION016847-001Approved Prior to Jan 1, 19823,476,802► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Chubb
Queensland Health
US Army
Federal Trade Commission
Merck
Cantor Fitzgerald
Harvard Business School
McKinsey
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot